When was Lifecode founded?

Lifecode was founded in 2012 and raised its 1st funding round 3 years after it was founded.

Where is Lifecode located?

Lifecode is headquartered in Foster City, United States.

How many employees does Lifecode have?

As of Apr 30, 2026, the latest employee count at Lifecode is 4.

Is Lifecode a funded company?

Lifecode is a funded company, having raised a total of $***** in its 1st and only funding round, a Series A round on Feb 18, 2015.

When was the latest funding round of Lifecode?

Lifecode's latest funding was a $***** Series A round on Feb 18, 2015, with participation from 2 investors. Its primary sector is Genomics. In United States, the Genomics sector has seen $424M in funding in 2026 to date.

Where does Lifecode rank among its competitors?

Lifecode ranks 31st amongst 177 active competitors, of which 62 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Volition, which secured an undisclosed amount in Mar, 2026.

Who are the top competitors of Lifecode?

Lifecode's top competitors include Invitae, Myriad Genetics and GRAIL. Among them, Volition secured the most recent funding round in March, 2026.

Lifecode - 2026 Company Profile, Team, Funding & Competitors

Company Details

Actionable cancer information through genomic sequencing and clinical data interpretation. It improves patient lives by providing patient-specific molecular information. The company analyzes and interprets genomic and therapeutic data via next-generation sequencing. It translates complex information for patients, payers, and providers. The company has a team with expertise in data science, software engineering, computational biology, bioinformatics, machine learning, curation science, molecular biology, and pathology. It offers the Pan Cancer Somatic Panel assay. The company focuses on genomically driven, personalized cancer care, working on the computational interpretation of human cancer to improve patient care. It is a clinical laboratory.

Website: lifecodehealth.com
Social

Key Metrics

Founded Year

2012

Location

Foster City, United States

Stage

Acquired

Total Funding

$20.5M in 1 round

Latest Funding Round

Series A, Feb 18, 2015, $*****

Investors

Sequoia Capital & 3 more

Ranked

31^st among 177 active competitors

Employee Count

4 as on Apr 30, 2026

Similar Companies

Invitae & 249 more

Exit Details

Acquired by MedGenome (Feb 24, 2016)

View Lifecode's full profile

Lifecode is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Lifecode, Inc. CIN: 452929135 , United States, Active	Dec 31, 2011	-	-	-

Lifecode got acquired by MedGenome on Feb 24, 2016.

Click here to take a look at Lifecode's acquisition in detail

Lifecode has raised a total funding of $20.5M over 1 round. Its latest funding round was a Series A round on Feb 18, 2015 for $*****. 2 investors participated in its latest round. Lifecode has 4 institutional investors.

Here is the list of recent funding rounds of Lifecode:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 18, 2015	8215864	Series A	1926226	6566292	5370992	8337116

Access funding benchmarks and valuations. Sign up today!

View details of Lifecode's funding rounds and investors

The founders of Lifecode are Eugene Fratkin and Sivan Bercovici.

Here are the details of Lifecode's key team members:

Eugene Fratkin: VP of Research and Development, Co-Founder of Lifecode.
Sivan Bercovici: CTO, Co-Founder of Lifecode.
Contact Info: 1 email address

View details of Lifecode's Founder profiles and Board Members

Lifecode's employee count trend

Lifecode has 4 employees as of Apr 26. Here is Lifecode's employee count trend over the years:

Uncover Lifecode's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Lifecode include Invitae, Myriad Genetics and GRAIL. Here is the list of Top 10 competitors of Lifecode, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Invitae 2010, San Francisco (United States), Public	Provider of home-based genetic test for individuals	$190M	Wellington, Deerfield & 22 others	77/100
2nd	Myriad Genetics 1991, United States, Public	Developer of molecular diagnostics and personalized medicine for cancer	-	Grayhawk Capital, TriplePoint Capital & 6 others	72/100
3rd	GRAIL 2016, Menlo Park (United States), Public	Developer of a screening platform for circulating tumor DNA to detect cancer	$2B	Arch Venture Partners, Sutter Hill Ventures ... & 51 others	72/100
4th	Fulgent Genetics 2011, Temple City (United States), Acquired	Provider of genetic testing services for carrier screening cardiovascular diseases, epilepsy and cancer	$34.8M	-	71/100
5th	UDX 2012, Seville (Spain), Series C	Developer of non-invasive blood-based diagnostics for cancer	$105M	Quest Diagnostics, Olympus & 6 others	67/100
6th	Celmatix 2009, New York City (United States), Series C	Pioneering ovarian health therapeutics for women's unique biological needs	$24.9M	Topspin Consumer Partners, Partnership for New York City ... & 4 others	66/100
7th	Volition 1995, Gembloux (Belgium), Public	Developer of cancer diagnostic tests	-	Namur Invest, Belgium & 1 others	61/100
8th	Genome Medical 2016, Monterey (United States), Series D	Provider of clinical and DTC genomic testing services	$173M	Samsung Catalyst Fund, Casdin Capital & 21 others	58/100
9th	Biovica 2009, Uppsala (Sweden), Public	Drug response monitoring assay	$4.27M	EIC Fund, Europa	55/100
10th	Mursla 2017, London (United Kingdom), Seed	Provider of diagnostic device for cancer detection	$547K	Future Fund, TA Ventures & 26 others	55/100
31st	Lifecode 2012, Foster City (United States), Acquired	Actionable cancer information through genomic sequencing and clinical data interpretation	$20.5M	Sequoia Capital, Mayo Clinic Business Accelerator ... & 2 others	45/100